Tag: cancer

biotech

DISCO Pharmaceuticals enters licence agreement with Amgen on cancer

biotech

Awakening dormant immune cells inside tumours to attack cancer​

biotech

Positive data moving breast cancer trial forward

biotech

Engineering dendritic cells boosts cancer immunotherapy

biotech

FDA clears allogeneic CAR-T recurrent glioblastoma therapy for phase II trial

biotech

Base to Base biotech podcast 40: Anchored immunotherapy, and healing the skin

biotech

First precision therapy prostate cancer drug approved

biotech

Breast cancer vaccine endpoints met with 74% immune response